Antiretroviral combination therapy and HIV infection. Such treatment improved CD4 counts in Scottish patients
McMenamin, J.; Allardice, G.; Goldberg, D.; Parpia, T.; Raab, G.; Parpira, T.
Bmj 317(7162): 887
1998
ISSN/ISBN: 0959-8138 PMID: 9748196 Document Number: 486646
Document emailed within 1 workday
Related Documents
Almeida, J.M.; Letang, E.; Nhampossa, T.; Ayala, E.; David, C.; Menendez, C.; Gascon, J.; Alonso, P.; Naniche, D. 2011: Rapid suppression of HIV-RNA is associated with improved control of immune activation in Mozambican adults initiating antiretroviral therapy with low CD4 counts Aids Research and Human Retroviruses 27(7): 705-711Feinstein, L.; Edmonds, A.; Okitolonda, V.; Cole, S.R.; Van Rie, A.; Chi, B.H.; Ndjibu, P.; Lusiama, J.; Chalachala, J.L.; Behets, F. 2015: Implementation and Operational Research: Maternal Combination Antiretroviral Therapy Is Associated with Improved Retention of HIV-Exposed Infants in Kinshasa, Democratic Republic of Congo Journal of Acquired Immune Deficiency Syndromes 69(3): E93-E99
Cervia, J.S. 2016: Addressing the Needs of Youth With HIV Infection in the Era of Combination Antiretroviral Therapy Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 62(7): 947
Woodd, S.L.; Grosskurth, H.; Levin, J.; Amuron, B.; Namara, G.; Birunghi, J.; Coutinho, A.; Jaffar, S. 2014: Home-based versus clinic-based care for patients starting antiretroviral therapy with low CD4⁺ cell counts: findings from a cluster-randomized trial Aids 28(4): 569-576
2001: Acceptance of antiretroviral therapy. HIV-infected patients assess convenient triple combination MMWFortschrittederMedizin 143(35-36): 56
Fox, R.; Gourlay, Y.J. 2000: The impact of highly active antiretroviral combination therapy in HIV infected patients in Glasgow Health Bulletin 58(4): 309-315
Waisman, J.L.; Palmero, D.J.; Alberti, F.A.; Güemes Gurtubay, J.L.; Francos, J.L.; Negroni, R. 2001: Improved prognosis in HIV/AIDS related multi-drug resistant tuberculosis patients treated with highly active antiretroviral therapy Medicina 61(6): 810-814
Iurin, O.G. 2007: Indications for initiation of antiretroviral therapy in patients with HIV infection. Choice of first-line drugs and schemes of therapy Terapevticheskii Arkhiv 79(11): 67-69
Di Giambenedetto, S.; Zazzi, M.; Corsi, P.; Gonnelli, A.; Di Pietro, M.; Giacometti, A.; Almi, P.; Trezzi, M.; Boeri, E.; Gianotti, N.; Menzo, S.; Del Gobbo, R.; Francisci, D.; Nerli, A.; Galli, L.; De Luca, A. 2009: Evolution and predictors of HIV type-1 drug resistance in patients failing combination antiretroviral therapy in Italy Antiviral Therapy 14(3): 359-369
Koole, O.; Houben, R.Mgj.; Mzembe, T.; Van Boeckel, T.P.; Kayange, M.; Jahn, A.; Chimbwandira, F.; Glynn, J.R.; Crampin, A.C. 2014: Improved retention of patients starting antiretroviral treatment in Karonga District, northern Malawi, 2005-2012 Journal of Acquired Immune Deficiency Syndromes 67(1): E27-E33
Mutwa, P.R.; Boer, K.R.; Asiimwe-Kateera, B.; Tuyishimire, D.; Muganga, N.; Lange, J.M.A.; van de Wijgert, J.; Asiimwe, A.; Reiss, P.; Geelen, S.P.M. 2014: Safety and effectiveness of combination antiretroviral therapy during the first year of treatment in HIV-1 infected Rwandan children: a prospective study Plos one 9(11): E111948
Hengge, U.R.; Goos, M.; Esser, S.; Exner, V.; Dötterer, H.; Wiehler, H.; Borchard, C.; Müller, K.; Beckmann, A.; Eppner, M.T.; Berger, A.; Fiedler, M. 1998: Randomized, controlled phase II trial of subcutaneous interleukin-2 in combination with highly active antiretroviral therapy (HAART) in HIV patients Aids 12(17): F225-F234
Patel, M.R.; Nana, M.; Yotebieng, M.; Tabala, M.; Behets, F.; Van Rie, A. 2014: Delayed antiretroviral therapy despite integrated treatment for tuberculosis and HIV infection International Journal of Tuberculosis and Lung Disease: the Official Journal of the International Union Against Tuberculosis and Lung Disease 18(6): 694-699
Pasquet, A.; Messou, E.èn.; Gabillard, D.; Minga, A.; Depoulosky, A.; Deuffic-Burban, S.; Losina, E.; Freedberg, K.A.; Danel, C.; Anglaret, X.; Yazdanpanah, Y. 2010: Impact of drug stock-outs on death and retention to care among HIV-infected patients on combination antiretroviral therapy in Abidjan, Côte d'Ivoire Plos one 5(10): E13414
Lo, Y.-C.; Chen, M.-Y.; Sheng, W.-H.; Hsieh, S.-M.; Sun, H.-Y.; Liu, W.-C.; Wu, P.-Y.; Wu, C.-H.; Hung, C.-C.; Chang, S.-C. 2009: Risk factors for incident diabetes mellitus among HIV-infected patients receiving combination antiretroviral therapy in Taiwan: a case-control study HIV Medicine 10(5): 302-309
Moore, D.M.; Awor, A.; Downing, R.S.; Were, W.; Solberg, P.; Tu, D.; Chan, K.; Hogg, R.S.; Mermin, J. 2007: Determining eligibility for antiretroviral therapy in resource-limited settings using total lymphocyte counts, hemoglobin and body mass index Aids Research and Therapy 4: 1
Cameron, D.W.; Japour, A.J.; Xu, Y.; Hsu, A.; Mellors, J.; Farthing, C.; Cohen, C.; Poretz, D.; Markowitz, M.; Follansbee, S.; Angel, J.B.; McMahon, D.; Ho, D.; Devanarayan, V.; Rode, R.; Salgo, M.; Kempf, D.J.; Granneman, R.; Leonard, J.M.; Sun, E. 1999: Ritonavir and saquinavir combination therapy for the treatment of HIV infection Aids 13(2): 213-224
Thuret, I. 2004: Infection à VIH de l'enfant : quand débuter le traitement antirétroviral ? - When to initiate antiretroviral therapy in HIV-infected children? Archives de Pediatrie (Paris) 11(12): 1521-1524
Benetucci, J.; Carlevaro, R.én.; Diez, M.ía.S.; Thwaites, A.; Cappello, S.; Garone, D.; Montero, A. 2002: Effect of age on CD4+ cells regeneration in patients with hiv infection undergoing triple antiretroviral therapy Medicina 62(1): 105-106
Shastri, S.; Boregowda, P.H.; Rewari, B.B.; Tanwar, S.; Shet, A.; Kumar, A.M.V. 2013: Scaling up antiretroviral treatment services in Karnataka, India: impact on CD4 counts of HIV-infected people Plos one 8(8): E72188